Dr. Neal Shore reviews treatment options in metastatic castration-resistant prostate cancer available in 2020.
EP. 1: Overview of Metastatic Castration-Resistant Prostate Cancer
EP. 2: Genetic Testing in Metastatic Castration-Resistant Prostate Cancer
EP. 3: Genetic Testing: A Conversation with Your Patient
EP. 4: Newly Approved Agents for Metastatic Castration-Resistant Prostate Cancer
EP. 5: A Look at the PROfound Trial
EP. 6: The Role of PARP Inhibitors in Prostate Cancer
EP. 7: COVID-19 and Treating Metastatic Castration-Resistant Prostate Cancer
Study results show CVAC 2.0 is safe, efficacious for wide range of kidney stones
FDA Advisory Committee unanimously votes against talazoparib plus enzalutamide for mCRPC
FDA Advisory Committee finds evidence for UGN-102 inconclusive, cites uncertainty in benefit-risk
Pivotal trial launches of 64Cu-SAR-bisPSMA in BCR of prostate cancer